{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:21:34Z","timestamp":1781594494836,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00223-010-9414-8","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T03:49:20Z","timestamp":1284349760000},"page":"398-405","source":"Crossref","is-referenced-by-count":25,"title":["Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1\u201334) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation"],"prefix":"10.1007","volume":"87","author":[{"given":"M.","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fogelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"9414_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"Consortium ADHR (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"9414_CR2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Tamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphataemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"9414_CR3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1744-9987.2007.00513.x","volume":"11","author":"H Juppner","year":"2007","unstructured":"Juppner H (2007) Novel regulators of phosphate homeostasis and bone metabolism. Ther Apher Dial 11(Suppl 1):S3\u2013S22","journal-title":"Ther Apher Dial"},{"key":"9414_CR4","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549","journal-title":"J Biol Chem"},{"key":"9414_CR5","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","volume":"288","author":"M Ito","year":"2005","unstructured":"Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto KI (2005) Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metab 288:E1101\u2013E1109","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9414_CR6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","volume":"20","author":"MT Collins","year":"2005","unstructured":"Collins MT, Linsaay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK (2005) Fibroblast growth factor-23 is regulated by 1alpha, 25-dihydroxyvitamin D. J Bone Miner Res 20:1944\u20131950","journal-title":"J Bone Miner Res"},{"key":"9414_CR7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SM Burnett","year":"2006","unstructured":"Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, JSl Finkelstein (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187\u20131196","journal-title":"J Bone Miner Res"},{"key":"9414_CR8","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M (2009) Fgf-23 decreases renal Na Pi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297:F282\u2013F291","journal-title":"Am J Physiol Renal Physiol"},{"key":"9414_CR9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305\u20131315","journal-title":"J Am Soc Nephrol"},{"key":"9414_CR10","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18:2683\u20132688","journal-title":"J Am Soc Nephrol"},{"key":"9414_CR11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4065\/79.12.1508","volume":"79","author":"PJ Tebben","year":"2004","unstructured":"Tebben PJ, Singh RJ, Clarke BL, Kumar R (2004) Fibroblast growth factor 23, parathyroid hormone, and 1alpha, 25-dIhydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc 79:1508\u20131513","journal-title":"Mayo Clin Proc"},{"key":"9414_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2004.05.026","volume":"44","author":"T Sato","year":"2004","unstructured":"Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M (2004) Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 44:481\u2013487","journal-title":"Am J Kidney Dis"},{"key":"9414_CR13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","volume":"67","author":"S Nakanishi","year":"2005","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67:1171\u20131178","journal-title":"Kidney Int"},{"key":"9414_CR14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","volume":"73","author":"P Urena Torres","year":"2008","unstructured":"Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prie D (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73:102\u2013107","journal-title":"Kidney Int"},{"key":"9414_CR15","doi-asserted-by":"crossref","unstructured":"Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease. Bone. doi: 10.1016\/j.bone.2009.08.008","DOI":"10.1016\/j.bone.2009.08.008"},{"key":"9414_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000210389","volume":"111","author":"F Daji","year":"2009","unstructured":"Daji F, Shiizaki K, Shimada S, Okada T, Kunimoto K, Sakaguchi T, Hatamura I, Shigematsu T (2009) Regulation of fibroblast growth factor 23 production in bone in uremic rats. Nephron 111:61\u201368","journal-title":"Nephron"},{"key":"9414_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-07-0534","volume":"158","author":"R Marsell","year":"2008","unstructured":"Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellstrom D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE (2008) Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol 158:125\u2013129","journal-title":"Eur J Endocrinol"},{"key":"9414_CR18","first-page":"267A","volume":"15","author":"H Hasegawa","year":"2004","unstructured":"Hasegawa H, Shimada T, Yamazaki Y (2004) Parathyroid-dependent and -independent mechanism to elevate serum concentration of FGF-23. J. Am Soc Nephrol 15:267A","journal-title":"J. Am Soc Nephrol"},{"key":"9414_CR19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1359\/jbmr.090406","volume":"24","author":"SM Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SM, Henao MP, Dere ME, Alaee H, Leder BZ (2009) Effects of hPTH(1\u201334) infusion on circulating serum phosphate, 1, 25-dihydroxyvitamin D and FGF23 levels in healthy men. J Bone Miner Res 24:1681\u20131685","journal-title":"J Bone Miner Res"},{"key":"9414_CR20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bone.2007.01.017","volume":"40","author":"Y Yoshiko","year":"2007","unstructured":"Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40:1565\u20131573","journal-title":"Bone"},{"key":"9414_CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23:939\u2013948","journal-title":"J Bone Miner Res"},{"key":"9414_CR22","doi-asserted-by":"crossref","first-page":"e10000154","DOI":"10.1371\/journal.pgen.1000154","volume":"4","author":"D Sitara","year":"2008","unstructured":"Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schuler C, Erben RG, Lanske B (2008) Genetic evidence of serum phosphate-independent functions of fgf-23 on bone. PLOS Genet 4:e10000154","journal-title":"PLOS Genet"},{"key":"9414_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","volume":"94","author":"K Wesseling-Perry","year":"2009","unstructured":"Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, J\u00fcppner H, Salusky IB (2009) Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511\u2013517","journal-title":"J Clin Endocrinol Metab"},{"key":"9414_CR24","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in post-menopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"9414_CR25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434\u20131446","journal-title":"Bone"},{"key":"9414_CR26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","volume":"37","author":"H Keller","year":"2005","unstructured":"Keller H, Kneissel M (2005) SOST is a target gene for PTH in bone. Bone 37:148\u2013158","journal-title":"Bone"},{"key":"9414_CR27","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O\u2019Brien CA, Manolagas SC, Jilka RL (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577\u20134583","journal-title":"Endocrinology"},{"key":"9414_CR28","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","volume":"3","author":"CA O\u2019Brien","year":"2008","unstructured":"O\u2019Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T (2008) Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS ONE 3:e2942","journal-title":"PLoS ONE"},{"key":"9414_CR29","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/ndt\/gfm268","volume":"22","author":"G Archibald","year":"2007","unstructured":"Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, Slane P, Whitworth C, Williams B (2007) UK consensus conference on early chronic kidney disease\u20136 and 7. Nephrol Dial Transplant 22:2455\u20132457","journal-title":"Nephrol Dial Transplant"},{"key":"9414_CR30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.071117","volume":"23","author":"F Joseph","year":"2008","unstructured":"Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP (2008) Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. J Bone Miner Res 23:721\u2013729","journal-title":"J Bone Miner Res"},{"key":"9414_CR31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1359\/jbmr.060802","volume":"21","author":"P Chen","year":"2006","unstructured":"Chen P, Miller PD, Delmas PD, Misurki DA, Krege JH (2006) Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res 21:1785\u20131790","journal-title":"J Bone Miner Res"},{"key":"9414_CR32","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2008-0353","volume":"93","author":"PD Miller","year":"2008","unstructured":"Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP (2008) Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab 93:3785\u20133793","journal-title":"J Clin Endocrinol Metab"},{"key":"9414_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RGG Russell","year":"2008","unstructured":"Russell RGG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733\u2013759","journal-title":"Osteoporos Int"},{"key":"9414_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00774-009-0101-7","volume":"28","author":"C Keel","year":"2010","unstructured":"Keel C, Kraenzlin ME, Kraenzlin CA, Muller B, Meier C (2010) Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. J Bone Miner Metab 28:68\u201376","journal-title":"J Bone Miner Metab"},{"key":"9414_CR35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","volume":"94","author":"R Eastell","year":"2009","unstructured":"Eastell R, Arnold A, Brandi ML, Brown EM, D\u2019Amour P, Hanley DA, Sudhaker Rao D, Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R, Lewiecki EM (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:340\u2013350","journal-title":"J Clin Endocrinol Metab"},{"key":"9414_CR36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/000456307781646102","volume":"44","author":"BH Durham","year":"2007","unstructured":"Durham BH, Joseph F, Bailey LM, Fraser WD (2007) The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by 3 commercial assays. Ann Clin Biochem 44:463\u2013466","journal-title":"Ann Clin Biochem"},{"key":"9414_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz C, Juppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D and FGF-23. Annu Rev Med 61:91\u2013104","journal-title":"Annu Rev Med"},{"key":"9414_CR38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey O (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"9414_CR39","unstructured":"Rhee Y, Farrow E, Lee R, Bivi N, Lazcano V, Plotkin L, White K, Bellido T (2009) FGF23 expression is upregulated by PTH receptor activation in osteocytes in vitro and in vivo: a parathyroid-bone link influencing the endocrine function of osteocytes. J Bone Miner Res 24 (suppl 1). http:\/\/www.asbmr.org\/ Meetings\/Annual meeting\/A09001860 (accessed March 6, 2010)"},{"key":"9414_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","volume":"94","author":"WW Brown","year":"2008","unstructured":"Brown WW, Juppner H, Langman CB, Price H, Farrow EG, White KE, Mc Cormick KL (2008) Hypophosphatemia with elevations in FGF-23 in a child with Jansen\u2019s metaphyseal chondrodysplasia. J Clin Endocrinol Metab 94:17\u201320","journal-title":"J Clin Endocrinol Metab"},{"key":"9414_CR41","first-page":"45","volume":"49","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Russell RG, Smith R (1975) Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man. Clin Sci Mol Med 49:45\u201356","journal-title":"Clin Sci Mol Med"},{"key":"9414_CR42","doi-asserted-by":"crossref","first-page":"F497","DOI":"10.1152\/ajprenal.1978.234.6.F497","volume":"234","author":"JP Bonjour","year":"1978","unstructured":"Bonjour JP, Troehler U, Preston C, Fleisch H (1978) Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates. Am J Physiol Renal Physiol 234:F497\u2013F505","journal-title":"Am J Physiol Renal Physiol"},{"key":"9414_CR43","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","volume":"95","author":"K Wesseling-Perry","year":"2010","unstructured":"Wesseling-Perry K, Harkins GC, Wang H, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Juppner H, Salusky IB (2010) The calcemic response to continuous parathyroid hormone (PTH) (1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH (7\u201384). J Clin Endocrinol Metab 95:2772\u20132780","journal-title":"J Clin Endocrinol Metab"},{"key":"9414_CR44","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","volume":"150","author":"R Samadfam","year":"2009","unstructured":"Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I, Goltzman D (2009) Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150:4835\u20134845","journal-title":"Endocrinology"},{"key":"9414_CR45","first-page":"358","volume":"6","author":"T Bellido","year":"2006","unstructured":"Bellido T (2006) Downregulation of SOST\/Sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes. J Musculoskelet Neuronal Interact 6:358\u2013359","journal-title":"J Musculoskelet Neuronal Interact"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9414-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-010-9414-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9414-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:37:59Z","timestamp":1558683479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-010-9414-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["9414"],"URL":"https:\/\/doi.org\/10.1007\/s00223-010-9414-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}